SOURCE: Bellwether Report

March 16, 2005 12:02 ET

Bellwether Report Begins Research on ARTC, BDCO, KERX and EPMN

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by The Bellwether Report.

TORONTO -- (MARKET WIRE) -- March 16, 2005 -- The Bellwether Report is the leading online financial newsletter, focusing on small-cap emerging growth opportunities. We strive to introduce investors to truly undervalued opportunities in a time-friendly fashion, allowing for optimal entry points and profitable exit points. Today, we will be tracking the following companies to gauge the short-term sentiment of their market: Arthocare CP (NASDAQ: ARTC), Blue Dolphin Energy Co. (NASDAQ: BDCO), Keryx Biopharm Inc. (NASDAQ: KERX) and Epimmune Inc. (NASDAQ: EPMN). Investors in any of the above-mentioned companies are invited to sample the Bellwether Report for 30 days complimentary, and receive a full report on the company of your choosing.

Arthocare CP was trading up 11% following its upgrading by First Albany.

Blue Dolphin Energy Co. was trading up 9% after filing SEC Form 8-K.

Keryx Biopharm Inc. was trading up 10% following its announcement of a special unbelievable performance improvement wireless network.

Lastly, Epimmune Inc. was up 9% after its agreement to combine businesses.

For 30 days complimentary with the BWR service feel free to visit and sign up. No credit card needed!!

The Bellwether Report to date has not been compensated by any of the above-mentioned companies.

Contact Information